RE:RE:RE:RE:RE:RE:RE:New Question - Restructuringsuitman87 wrote: nope you are wrong, don't tell false info. the 10 products are already awaiting approval. and the next 14 are expected for a release within the next 1-3 years. i don't understand your confusion this info was in the most recent report. if your info is incorrect, perhaps you should sit down and play with your toys while us men discuss business.
HEALTH IS CORRECT. Page 9 of the earnings call transcript, available on SA contirms the 8 products will come on three to five years, the remaining later. Do you have trouble with your english comprehension Suitman?
Cut and paste from the earnings transcript from Wednesday:
Allan Oberman:
With respect to the eight products that we anticipate will provide us certain first-to-market or early-to-market opportunities for some of them, we described those as products that we would envision coming to market in three to five years. And then finally with the remaining 14 products that we've begun to think about and begun to develop, one could anticipate those also in that three, four, five-year timeframe. None of our products at this particular moment have we thought out 10 years. So in total as you can see, we have 32 spread over let’s say the next five years.